| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e14bc7432cd03b2fec703f85c49df3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30e3d9a67afa6afa028710e48ff7b1da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0339033e6b4f134912d88cfaf930ed55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2817954cd008bcd609a4c4eb49050be |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2012-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5386c1697a3800367481d3482e05987
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75b01af953baa392bea8e2cce274daee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b16227e5235d7cac365755cce166e4a2 |
| publicationDate |
2012-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012230978-A1 |
| titleOfInvention |
Compositions and methods for modulating circadian synchronization |
| abstract |
The present invention relates to a modulator of glucocorticoid biosynthesis, degradation and/or receptor activation for use in preventing or treating symptoms and/or diseases associated with jet lag. The compositions of the invention may be used as a lead compound for developing a drug for preventing or treating symptoms and/or diseases associated with jet lag. The invention relates to the discovery that administration of the modulator(s) to a subject results in a directional change of the time point of maximum amounts of glucocorticoids in the subject as compared to the time point of maximum amounts of glucocorticoids in a subject not treated with the modulator(s). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113593695-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11389427-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018148531-A1 |
| priorityDate |
2011-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |